| 摘要: |
| 石莼多糖是一种源自绿藻石莼的硫酸化多糖,具有结构复杂、生物相容性好和低毒性的特点。研究表明,石莼多糖通过多种分子机制发挥显著的抗肿瘤活性,且石莼多糖与现有化疗药物联用可产生协同增效作用,并有助于减轻化疗引起的毒副作用,显示出作为新型抗肿瘤佐剂或药物的潜力。未来的研究重点在于深入阐明其精确的作用机制,并推动规范化的临床转化,这为开发高效低毒的肿瘤治疗新策略提供了重要方向。 |
| 关键词: 石莼多糖 抗肿瘤活性 构效关系 多靶点作用 辅助治疗 |
| DOI:10.13506/j.cnki.jpr.2026.07.011 |
| 基金项目:广东省协同创新与平台环境建设项目(No.2017A040404052);广东省级促进经济发展专项资金(海洋经济发展用途)项目(No.GDME-2018C011) |
|
收稿日期:2026-01-08
修回日期:2026-04-16
出版日期:2026-07-31
|
|
| Research progress of ulva polysaccharide in cancer |
| ZHENG Jiamin1,GUO Long1,DING Hongyan1,ZOU Liyi2,LIU Yi1 |
| (1. School of Ocean and Tropical Medicine, Guangdong Medical University, Zhanjiang 524023, China; 2. School of Pharmacy, Guangdong Medical University, Dongguan 523808, China) |
| Abstract: |
| Ulva polysaccharide, a sulfated polysaccharide derived from the green alga Ulva, is characterized by its structural complexity, good biocompatibility, and low toxicity. Research has demonstrated its significant anti-tumor activity through various molecular mechanisms. Notably, Ulva polysaccharide exhibits synergistic effects when combined with conventional chemotherapeutic agents and can help alleviate their associated side effects, highlighting its potential as a novel anti-tumor adjuvant or therapeutic agent. Future research should focus on elucidating its precise mechanisms of action and promoting standardized clinical translation, which offers important direction for developing new, efficient, and low-toxicity strategies for cancer therapy. |
| Key words: Ulva polysaccharide, Antitumor activity, Structure-activity relationship, Multi-target mechanism, Adjunctive therapy |